at about the 34 minute mark, Scott Kelly said: We
Post# of 148154
(Total Views: 593)
Posted On: 07/13/2022 7:39:37 PM
at about the 34 minute mark, Scott Kelly said:
and again at:
Quote:
We want to address questions on Patents. I want people to understand that we have a highly qualified duteek firm that has handled our IP portfolio for many years. Since LRM is a biologic, it will receive 12 years of exclusivity if approved. The original patent composition of matter does expire in 2023, but the Concentrated Protein Formulation does not expire until 2031, and this is what has been used in all our clinical studies. We will also pursue methods that use patents LRM in a novel way across many indications.
and again at:
Quote:
43:56 Christine: So do we have a filed patent for each indication we use LRM on or is 1 patent overreaching?
Scott Kelly: So again to emphasize, our protein concentration formula that has been used in all our clinical trials, lasts until 2031. Now upon approval, biologics get 12 years of exclusivity, so we will continue to pursue methods of these patents which is essentially patents for LRM in various indications based on MOA.
(9)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼